Vanda Pharmaceuticals Inc (VNDA)
Cost of Revenue
$15.49M
TTM · Period ending: · USD
VNDA Cost of Revenue
Latest reported$15.49Mperiod ending
Latest reported$15.49Mperiod ending
VNDA TTM Cost of Revenue ($0.00 → $15.49M)
TTM cost of revenue
High-resolution chart · PNG
VNDA cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 15,493,000 | |
| 16,420,000 | |
| 14,795,000 | |
| 13,552,000 | |
| 13,149,000 | |
| 13,147,000 | |
| 15,084,000 | |
| 15,954,000 | |
| 16,466,000 | |
| 15,480,000 | |
| 14,796,000 | |
| 17,574,000 | |
| 20,831,000 | |
| 23,391,000 | |
| 24,282,000 | |
| 24,280,000 | |
| 24,757,000 | |
| 25,264,000 | |
| 25,629,000 | |
| 25,805,000 | |
| 24,906,000 | |
| 24,187,000 | |
| 23,364,000 | |
| 23,177,000 | |
| 24,061,000 | |
| 24,582,000 | |
| 24,488,000 | |
| 23,930,000 | |
| 22,216,000 | |
| 21,061,000 | |
| 20,508,000 | |
| 19,632,000 | |
| 19,089,000 | |
| 18,405,000 | |
| 17,848,000 | |
| 18,329,000 | |
| 20,794,000 | |
| 22,759,000 | |
| 24,712,000 | |
| 25,611,000 | |
| 25,131,000 | |
| 24,403,000 | |
| 23,462,000 | |
| 17,973,000 | |
| 12,166,000 | |
| 6,598,000 | |
| 1,583,000 | |
| 901,000 | |
| 198,000 | |
| 0 | |
| 0 | |
| 129,000 | |
| 129,000 | |
| 129,000 | |
| 129,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,117,835 | |
| -741,043 | |
| 1,147,081 | |
| 2,891,000 | |
| 6,300,317 | |
| 6,300,317 | |
| 4,641,545 | |
| 2,897,626 | |
| 606,144 | |
| 229,352 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |